Proscia, a Philadelphia-based digital pathology platform has raised $8.3 million in Series A funding led by Boston-based Flybridge Capital Partners with participation from Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures, and RobinHood Ventures.The startup plans to utilize the Series A funding to fuel the development and commercialization of new, clinical AI-enabled workflows targeting high-volume, high-impact cancers, the first of which will be available later this year. In
Read More
Digital Pathology
Philips Partners With Mass General to Advance Digital Pathology Adoption
Philips announced it’s collaborating with Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) to enable research, support clinical diagnosis and help advance digital pathology adoption across the U.S. through the implementation of the Philips IntelliSite Pathology Solution.This collaboration builds on digital pathology’s growing momentum in recent years, due to its ability to enable highly automated workflows that allow pathologists to compile clinically actionable
Read More
Philips Launches Informatics Platform to Advance Drug Research & Biomarker Discovery
Today, Philips has announced the launch of Xplore, a web-based image and data management platform that will help pharma and academic researchers speed up drug research and biomarker discovery through enhanced integration, visualization and analytics tools. Xplore v4.0 will be available commercially in July 2017. Customers have the option to purchase the basic package or with custom additions including a dedicated TMA module for enabling faster and streamlined research.As the industry continues
Read More
Philips Acquires Northern Irish Digital Pathology Startup PathXL
Today, Philips announced it has acquired PathXL, Northern Ireland-based leader in digital pathology image analysis, workflow software and educational tools to complement its IntelliSite Pathology Solution. With this move, Philips seeks to accelerate its drive to support medical institutions around the world as they move from microscopy-driven workflows to digitized pathology workflows. Financial details of the acquisition were not disclosed. Founded in 2004 and headquartered in Belfast, Northern
Read More
Massachusetts General Hospital Launches Digital Pathology Study
Massachusetts General Hospital (MGH) announced that it will serve as a key testing site for a clinical analytical study involving Philips’ digital pathology whole slide imaging (WSI) IntelliSite Solution. The study is designed to show the reproducibility of the IntelliSite pathology solution in disease detection as part of the industry’s efforts to obtain regulatory clearance of WSI for primary diagnostic use. If approved for diagnosis, in contrast to the industry’s current analog process, soon
Read More
Philips, Genomic Health Partner to Utilize Innovative Digital Pathology
Royal Philips has announced a collaboration with Genomic Health, Inc., a provider of genomic-based diagnostic tests, to leverage Philips digital pathology tools in Genomic Health’s continuing scale up of its molecular diagnostic testing processes. Pathology involves the examination of patient tissue samples and plays a crucial role in the diagnosis and treatment of a wide variety of diseases, including cancer. Pathologic evaluation of tumor tissue specimens is a critical step in the genomic
Read More
